2 exciting ASX growth shares to buy in September

Here's why I think that Appen Ltd (ASX:APX) and this exciting ASX growth share are in the buy zone right now for growth investors…

| More on:
wooden blocks with percentage signs being built into towers of increasing height

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

I believe that one of the best ways for investors to grow their wealth is to make long term investments in quality shares with strong business models and positive outlooks.

Two ASX growth shares that tick a lot of boxes for me right now are listed below.

Here's why I think they could provide outsized returns for their shareholders over the 2020s:

Appen Ltd (ASX: APX)

The first ASX growth share that I would buy right now is Appen. It is the global leader in the development of high-quality, human-annotated training data for machine learning and artificial intelligence. Appen has a very strong position in the industry thanks to its team of over 1 million crowd-sourced workers spread out across the globe.

This sizeable team allows the company to collect and label high volumes of image, text, speech, audio, and video data that is used to build and improve artificial intelligence models. Given the growing importance of artificial intelligence and machine learning for businesses and governments, I expect demand for its services to grow rapidly over the coming years. This should put the company in a position to continue growing its earnings at a strong rate long into the future.

PolyNovo Ltd (ASX: PNV)

Another ASX growth share to consider buying is PolyNovo. It is an exciting medical device company behind the increasingly popular NovoSorb technology. NovoSorb is a biodegradable material that was developed and CSIRO and is used to aid the repair of bone fractures and damaged cartilage, and also in skin grafts.

I believe the NovoSorb Biodegradable Temporising Matrix (BTM) product will be the key driver of growth in the future. It is a wound dressing intended to treat full-thickness wounds and burns and has a massive $1.5 billion market opportunity. Management also has plans to expand its use into other markets and has its eyes on the hernia and breast treatment markets. These would add a further $6 billion to its addressable market if successful.

James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of POLYNOVO FPO. The Motley Fool Australia owns shares of Appen Ltd. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Growth Shares

A bearded man holds both arms up diagonally and points with his index fingers to the sky with a thrilled look on his face over these rising Tassal share price
Growth Shares

3 unstoppable ASX shares to buy and hold for the next decade

These shares are going places over the remainder of the decade and beyond.

Read more »

Four piles of coins, each getting higher, with trees on them.
Growth Shares

2 high-growth ASX shares to buy today: brokers

These stocks have a strong growth outlook.

Read more »

Two university students in the library, one in a wheelchair, log in for the first time with the help of a lecturer.
Growth Shares

2 top-quality ASX shares to buy for beginner investors

These stocks could be a great place to start investing.

Read more »

A man in full American NFL playing kit crouches over with his arms across his chest in a defensive stance against a dark background.
Growth Shares

Here's why these two ASX 300 shares are great ones to own

These businesses are two of the fastest-growing stocks in the ASX 300 and are liked by fund manager WAM.

Read more »

A smiling businessman in the city looks at his phone and punches the air in celebration of good news.
Growth Shares

3 ASX growth shares you'll wish you bought in June

Analysts think these shares could be destined for big things in the future.

Read more »

Father and daughter with hands on a small plant.
ETFs

Focused on growth? Here are 3 ASX ETFs to consider

Growth investors must ignore the current market noise about tariffs and focus on the long-term horizon.

Read more »

A female broker in a red jacket whispers in the ear of a man who has a surprised look on his face as she explains which two ASX 200 shares should do well in today's volatile climate
Growth Shares

Top brokers name 3 top ASX growth shares to buy now

Why are brokers feeling bullish on these names? Let's find out.

Read more »

Two plants grow in jars filled with coins.
Growth Shares

3 ASX 200 growth stocks up more than 100% in 1 year that could charge higher

It's been a memorable year for shareholders of these 3 companies.

Read more »